Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the relative bioavailability of Lansoprazole DR
Capsules 30 mg with Prevacid® Capsules 30 mg under fasting conditions in healthy adult human
subjects.